Cigna Group $CI Stock Holdings Trimmed by Rosenberg Matthew Hamilton

Rosenberg Matthew Hamilton lowered its holdings in shares of Cigna Group (NYSE:CI) by 11.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 674 shares of the health services provider’s stock after selling 85 shares during the period. Rosenberg Matthew Hamilton’s holdings in Cigna Group were worth $223,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Family Legacy Inc. lifted its position in shares of Cigna Group by 0.5% in the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock worth $2,138,000 after buying an additional 31 shares during the last quarter. Impact Investors Inc lifted its position in shares of Cigna Group by 1.6% in the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock worth $650,000 after buying an additional 31 shares during the last quarter. Mission Wealth Management LP lifted its position in shares of Cigna Group by 1.5% in the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock worth $691,000 after buying an additional 32 shares during the last quarter. Westend Capital Management LLC lifted its position in shares of Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock worth $140,000 after buying an additional 32 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC lifted its position in shares of Cigna Group by 26.8% in the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock worth $53,000 after buying an additional 34 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. Truist Financial set a $375.00 price objective on Cigna Group in a research report on Tuesday, September 2nd. Cantor Fitzgerald reissued an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Finally, The Goldman Sachs Group assumed coverage on Cigna Group in a research report on Tuesday. They set a “buy” rating and a $370.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $369.89.

Cigna Group Trading Down 2.4%

Shares of CI opened at $294.79 on Thursday. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $78.69 billion, a price-to-earnings ratio of 16.09, a P/E/G ratio of 0.89 and a beta of 0.45. The stock’s 50-day moving average price is $296.36 and its 200 day moving average price is $308.77.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the company posted $6.72 earnings per share. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date was Thursday, September 4th. Cigna Group’s dividend payout ratio is currently 32.97%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.